Universität Ulm

Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage (2019) Kuramatsu J, Biffi A, Gerner S, Sembill J, Sprügel M, Leasure A, Sansing L, et al. Journal article Wireless Sensor Platform for Detection of Vital Parameters of Bats (2019) Duda N, Ripperger S, Tschapka M, Mayer F, Weigel R, Kölpin A Conference contribution, Original article LACI: Low-effort Automatic Calibration of Infrastructure Sensors (2019) Muller J, Herrmann M, Strohbeck J, Belagiannis V, Buchholz M Conference contribution DeepLocalization: Landmark-based Self-Localization with Deep Neural Networks (2019) Engel N, Hoermann S, Horn M, Belagiannis V, Dietmayer K Conference contribution Mobile Apps in Rheumatology: Review and Analysis Using the Mobile App Rating Scale (MARS) (2019) Knitza J, Tascilar K, Messner EM, Meyer M, Vossen D, Pulla A, Bosch P, et al. Conference contribution Comparison between treatment of "established" versus complex "off-label" coronary lesions with Absorb bioresorbable scaffold implantation: results from the GABI-R registry (2019) Huseynov A, Baumann S, Nef H, Riemer T, Schneider S, Pfannebecker T, Achenbach S, et al. Conference contribution Synchronization of radar sensors in a network based on inter-sensor interference (2019) Steiner M, Keller M, Geiß J, Vossiek M, Waldschmidt C Conference contribution Utility of the CPS plus EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy (2019) Marme F, Solbach C, Michel L, Fasching P, Schneeweiss A, Blohmer JU, Rezai M, et al. Conference contribution Efficacy of anti-PD(L)1 treatment in patients with metastatic urothelial cancer based on mRNA- and protein- based PD-L1 determination: Results from the multicentric, retrospective FOsMIC trial (2019) Jarczyk J, Wirtz R, Roghmann F, Juette H, Kriegmair MC, Worst TS, Sikic D, et al. Conference contribution Prognostic role of FGFR Mutations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second-line setting (2019) Roghmann F, Wirtz R, Jarczyk J, Kriegmair MC, Worst TS, Sikic D, Wach S, et al. Conference contribution